Myriad Genetics, Inc. MYGN recently launched a patient home collection kit for its GeneSight Psychotropic test, enabling the DNA sample collection that is generally undergone
Myriad Genetics, Inc. MYGN recently launched a patient home collection kit for its GeneSight Psychotropic test, enabling the DNA sample collection that is generally undergone